FDA Enforcement Class II Terminated

Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).

Recall: Z-0801-2015 · Reported December 24, 2014

Enforcement

Recall Number
Z-0801-2015
Event ID
69718
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Siemens Healthcare Diagnostics, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 24, 2014
Initiation Date
October 27, 2014
Classification Date
December 12, 2014
Termination Date
March 10, 2017
Address
511 Benedict Ave, N/A, Tarrytown, NY, 10591-5005, United States

Description

Turbo Troponin I For in vitro diagnostic use for the quantitative measurement of troponin I in serum, heparinized or EDTA plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).

Code Info

Catalog #'s: 1) LSKTI1 and 2) LSKTI1(D); Siemens Material Number (SMN): 1) 10642238 (US) and 2) 10381014 (OUS); Lot Numbers: 319, 321, 322, 323 and D319, D321 and D322.

Distribution

Worldwide Distribution: US distribution in states of: CO, FL, MN, MT, and NY; and countries of: Algeria, Argentina, Bolivia, Brazil, Bulgaria, Chile, Columbia, Czech Republic, Ecuador, Egypt, Germany, Hungary, India, Italy, Lithuania, Latvia, Pakistan, Poland, Romania, Russian Fed., Serbia, South Africa, Slovakia, Thailand, Tunisia, and Uruguay.

Quantity

3,622 kits (3,572 domestic and 50 internationally)